港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

医药外包概念

2,480.574

-57.593-2.27%

涨家数：- -

跌家数：7

平家数：1

市盈率：- -

高：2,536.788

开：2,536.788

低：2,446.946

收：2,538.167

成交量：8,781.47万

成交额：28.41亿

市值：5,764.81亿

流通市值：2,430.42亿

数据加载中...

总览新闻资讯

昭衍新药(06127)获股东顾美芳解除质押140万股

智通财经网

每日卖空追踪 | 泰格医药 11月17日卖空量成交6.42万股，卖空比例为1.94%

每日卖空追踪 | 药明生物 11月17日卖空量成交170.4万股，卖空比例为3.25%

每日卖空追踪 | 金斯瑞生物科技 11月17日卖空量成交59.4万股，卖空比例为6.93%

泰格医药11月17日遭主力抛售46.7万元

药明康德(02359)出现大手卖出6.25万股，成交价$104.5，涉资653.125万

阿斯达克财经

药明康德的资本“迷局”

大摩沪港深精选混合基金经理：创新药产业迎发展新机遇

昭衍新药盘中异动急速跳水5.04%

金斯瑞生物科技（1548.HK）2025投资者开放日：战略蓝图首秀，迈向生物科技生态平台

药明生物盘中异动股价大跌3.00%

《股市简讯》康龙化成A股挫5%，两股东拟合计减持不超过1.5%股份

康龙化成获Norges Bank增持70.02万股每股作价约23.81港元

《细胞分选磁珠性能检测方法》国标发布，金斯瑞深度参与制定，助推行业标准化

医药生物行业研究周报：开源证券研究报医药生物MNC全面布局FGF21靶点关注国内投资机会

药明生物(02269.HK)根据购股权计划获行使增发300万股

药明康德激进的全球化：正在感受双重挤压？

Norges Bank增持康龙化成(03759)70.02万股每股作价约23.81港元

每日卖空追踪 | 昭衍新药 11月14日卖空量成交52.98万股，卖空比例为18.16%

药明康德11月14日获主力加仓1540.2万元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1576/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1576","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","market":"HK","secType":"PLATE","nameCN":"医药外包概念","latestPrice":2480.5737,"timestamp":1763366893506,"preClose":2538.1665,"halted":0,"volume":87814728,"delay":0,"changeRate":-0.022691,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-57.592773,"latestTime":"11-17 16:00:00","open":2536.7878,"high":2536.7878,"low":2446.9456,"amount":2840631448,"amplitude":0.035397,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1763429400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1763343000000,1763352000000],[1763355600000,1763366400000]],"pbRate":2.886545,"peRate":13.008034,"turnoverRate":0.007319,"increases":0,"decrements":7,"flats":1,"marketCap":576481092608,"floatMarketCap":243042411008},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","high":2536.7878,"amplitude":0.035397,"preClose":2538.1665,"low":2446.9456,"pbRate":"2.886545","latestPrice":2480.5737,"volume":87814728,"delay":0,"open":2536.7878,"prevYearClose":1395.7731,"prevWeekClose":2538.166,"prevMonthClose":2671.652,"prevQuarterClose":2949.096,"fiveDayClose":2540.308,"twentyDayClose":2561.102,"sixtyDayClose":2427.876,"secType":"PLATE","market":"HK","turnoverRate":0.007319,"peRate":13.008034,"marketCap":576481092608,"floatMarketCap":243042411008,"timestamp":1763366893506,"nameCN":"医药外包概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1576\",,,,undefined,":{"bkCode":"BK1576","up":0,"down":7,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1576\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584201643","title":"昭衍新药(06127)获股东顾美芳解除质押140万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2584201643","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584201643?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 16:55","pubTimestamp":1763369759,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昭衍新药(06127)发布公告，2025年11月17日，公司接到股东顾美芳女士将其持有公司部分质押股份解除质押的通知，本次解质股份140万股。截至本公告披露日，顾美芳女士持有公司股份1032.2万股，占公司总股本的1.38%股;本次股份解除质押后，顾美芳女士持有公司股份累计质押数量为500万股，占其持股数量的48.44%。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369990.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1141","603127","06127","BK1576","BK0216"],"gpt_icon":0},{"id":"2584642775","title":"每日卖空追踪 | 泰格医药 11月17日卖空量成交6.42万股，卖空比例为1.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584642775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584642775?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 16:30","pubTimestamp":1763368231,"startTime":"0","endTime":"0","summary":"泰格医药北京时间11月17日，跌6.61%，卖空量成交6.42万股，较上一交易日减少1.98%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117163516976e74d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117163516976e74d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","03347","BK1583"],"gpt_icon":0},{"id":"2584647266","title":"每日卖空追踪 | 药明生物 11月17日卖空量成交170.4万股，卖空比例为3.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584647266","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584647266?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 16:30","pubTimestamp":1763368227,"startTime":"0","endTime":"0","summary":"药明生物北京时间11月17日，跌2.88%，卖空量成交170.4万股，较上一交易日减少71.23%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117163415a6fee638&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117163415a6fee638&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0417516902.SGD","LU0708995583.HKD","BK1589","LU0819121731.USD","LU0307460666.USD","LU0051755006.USD","LU0516422952.EUR","LU0348735423.USD","LU0043850808.USD","SG9999002463.SGD","02269","LU0516422440.USD","LU0516423174.USD","LU0456846285.SGD","LU0052750758.USD","LU1242518931.SGD","LU0823426308.USD","LU0417516738.SGD","LU0326950275.SGD","IE00B0JY6N72.USD","LU0359202008.SGD","LU1688375341.USD","BK1521","LU0572944931.SGD","LU0456827905.SGD","LU0327786744.USD","LU3063872942.SGD","BK1610","LU0359201612.USD","LU0320764599.SGD","LU0856984785.SGD","LU0516423091.SGD","LU1794554557.SGD","BK1576","LU0588546209.SGD","LU0516422366.SGD","SG9999002562.SGD","LU1242518857.USD","LU0348825331.USD","LU0823426480.USD","LU2039709279.SGD","LU1880383366.USD","BK1141","LU0140636845.USD","LU1720050803.USD","LU0979878070.USD","LU0039217434.USD","LU0181495838.USD"],"gpt_icon":0},{"id":"2584428436","title":"每日卖空追踪 | 金斯瑞生物科技 11月17日卖空量成交59.4万股，卖空比例为6.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584428436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584428436?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 16:30","pubTimestamp":1763368220,"startTime":"0","endTime":"0","summary":"金斯瑞生物科技北京时间11月17日，跌1.68%，卖空量成交59.4万股，较上一交易日减少65.62%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111716330195097a63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111716330195097a63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1583","01548","HK0000306701.USD","HK0000320223.HKD","BK1141","HK0000320264.USD","HK0000306685.HKD"],"gpt_icon":0},{"id":"2584751642","title":"泰格医药11月17日遭主力抛售46.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584751642","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584751642?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 16:15","pubTimestamp":1763367312,"startTime":"0","endTime":"0","summary":"11月17日, 泰格医药股价跌6.61%，报收41.24元，成交金额1.4亿元，换手率2.69%，振幅6.97%，量比2.13。泰格医药今日主力资金净流出46.7万元，连续5日净流出，上一交易日主力净流出443.4万元。该股近5个交易日下跌9.57%，主力资金累计净流出1208.4万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入2788.7万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111716154395096faa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111716154395096faa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1583","03347","BK1141"],"gpt_icon":0},{"id":"2584170556","title":"药明康德(02359)出现大手卖出6.25万股，成交价$104.5，涉资653.125万","url":"https://stock-news.laohu8.com/highlight/detail?id=2584170556","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584170556?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 15:19","pubTimestamp":1763363940,"startTime":"0","endTime":"0","summary":"[大手成交]药明康德(02359)在下午03:19出现大手卖出，成交量为6.25万，成交价为港币$104.5，涉资653.125万。至目前为止，股价跌0.665%，今日最高价为$104.8，而最低价为$102.1，总成交量为397.595万股，总成交金额港币$4.097亿。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150431576_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150431576_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2511177467/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2045819591.USD","LU1997244956.HKD","LU1997245177.USD","LU1969619763.USD","603259","LU0320764599.SGD","LU1997245094.SGD","LU0456842615.SGD","LU2488822045.USD","BK0216","LU2242644610.SGD","LU1979443071.USD","02359","BK1583","LU1046422090.SGD","LU0052750758.USD","LU1934453819.USD","BK1576","LU2328871848.SGD","LU2495084118.USD","LU2125910500.SGD","LU0708995583.HKD","LU1808992512.USD","BK1141"],"gpt_icon":0},{"id":"2584100046","title":"药明康德的资本“迷局”","url":"https://stock-news.laohu8.com/highlight/detail?id=2584100046","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584100046?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 14:34","pubTimestamp":1763361240,"startTime":"0","endTime":"0","summary":"　　GLP-1风口终会过去，而过度依赖单一市场、核心股东不断套现带来的信任危机，可能才是药明康德未来要面对的真正挑战。　　2025年前三季度，药明康德交出了一份亮眼的成绩单：营收328.6亿元，同比增长18.6%；净利润高达120.8亿元，同比大增84.8%，毛利率和净利率均创历史新高。　　此举延续了药明康德近年来的资产调整路径。　　截至2025年9月末，药明康德持续经营业务在手订单高达598.8亿元，同比大增41.2%，已经直逼600亿“大关”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-17/doc-infxsxya6490674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1934453819.USD","LU2488822045.USD","LU1997245094.SGD","LU1969619763.USD","BK1141","BK1576","LU1979443071.USD","02359","LU0456842615.SGD","LU0052750758.USD","BK1583","LU1997244956.HKD","LU0320764599.SGD","BK0216","LU2045819591.USD","LU2495084118.USD","LU1046422090.SGD","LU2125910500.SGD","603259","LU2328871848.SGD","LU2242644610.SGD","LU0708995583.HKD","LU1997245177.USD","LU1808992512.USD"],"gpt_icon":0},{"id":"2584642749","title":"大摩沪港深精选混合基金经理：创新药产业迎发展新机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2584642749","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584642749?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 12:43","pubTimestamp":1763354625,"startTime":"0","endTime":"0","summary":"【11月17日大摩沪港深精选混合基金经理称创新药械产业进入新阶段】11月17日，大摩沪港深精选混合基金经理王大鹏透露，当前创新药械产业进步显著，开启国际化征程，对外授权持续落地。新一代创新药分子实体有竞争优势，全球创新产业地位提升。头部公司业绩盈利加速或转盈，代表性公司实现仿转创里程碑，产业进入新阶段。 海外药企需求复苏，外向型CDMO订单持续改善，国内部分CRO企业订单企稳回升。随着创新药支持政策落地，相关服务公司有持续恢复潜力。本文由 AI 算法生成，仅作参考，不涉投资建议，使用风险自担","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511171325019509288d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511171325019509288d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","03347","BK1161","BK1574","06978","BK1583","BK1141"],"gpt_icon":0},{"id":"2584616969","title":"昭衍新药盘中异动 急速跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584616969","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584616969?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 11:53","pubTimestamp":1763351592,"startTime":"0","endTime":"0","summary":"2025年11月17日临近午盘11时53分，昭衍新药股票出现波动，股价大幅下挫5.04%。截至发稿，该股报18.450港元/股，成交量266.235万股，换手率2.24%，振幅6.38%。昭衍新药股票所在的生物技术行业中，整体跌幅为3.18%。其相关个股中，中生北控生物科技、来凯医药-B、北海康成-B涨幅较大，振幅较大的相关个股有中生北控生物科技、派格生物医药-B、旺山旺水-B，振幅分别为62.14%、27.98%、18.26%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117115312a4a6a304&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117115312a4a6a304&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1576","BK1141"],"gpt_icon":0},{"id":"2584613688","title":"金斯瑞生物科技（1548.HK）2025投资者开放日：战略蓝图首秀，迈向生物科技生态平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2584613688","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584613688?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 11:10","pubTimestamp":1763349032,"startTime":"0","endTime":"0","summary":"随着战略路径的逐步兑现与生态协同效应的持续释放，金斯瑞正稳步迈向全球生物科技舞台的中心，一场由技术驱动、生态赋能的估值重塑，已然开启。","market":"sg","thumbnail":"https://img2.gelonghui.com/b17e2-10232ee3-ac69-4738-bfbf-5e1d28acc6e2.jpg?guru_height=720&guru_width=1280&guru_size=154189","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/b17e2-10232ee3-ac69-4738-bfbf-5e1d28acc6e2.jpg?guru_height=720&guru_width=1280&guru_size=154189"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/3207785","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["HK0000320264.USD","BK1576","BK1141","HK0000306701.USD","HK0000306685.HKD","01548","HK0000320223.HKD","BK1583"],"gpt_icon":0},{"id":"2584642814","title":"药明生物盘中异动 股价大跌3.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584642814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584642814?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 10:26","pubTimestamp":1763346364,"startTime":"0","endTime":"0","summary":"2025年11月17日早盘10时26分，药明生物股票出现异动，股价急速下挫3.00%。截至发稿，该股报32.320港元/股，成交量882.981万股，换手率0.22%，振幅3.00%。药明生物股票所在的生物技术行业中，整体跌幅为3.18%。其相关个股中，中生北控生物科技、旺山旺水-B、来凯医药-B涨幅较大，振幅较大的相关个股有派格生物医药-B、中生北控生物科技、旺山旺水-B，振幅分别为27.98%、21.36%、18.26%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117102604a4a677ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117102604a4a677ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320764599.SGD","LU0856984785.SGD","SG9999002562.SGD","IE00B0JY6N72.USD","LU0326950275.SGD","LU0417516902.SGD","LU1720050803.USD","LU0516422440.USD","LU0588546209.SGD","BK1521","LU0979878070.USD","LU1880383366.USD","LU1794554557.SGD","LU3063872942.SGD","BK1589","LU0516422952.EUR","LU0516423091.SGD","LU0417516738.SGD","LU0348735423.USD","LU0052750758.USD","BK1576","LU0327786744.USD","LU0456827905.SGD","LU0516422366.SGD","LU0043850808.USD","LU0051755006.USD","SG9999002463.SGD","LU2039709279.SGD","LU0516423174.USD","LU0823426308.USD","LU1242518857.USD","BK1141","LU0359201612.USD","LU1688375341.USD","BK1610","LU0708995583.HKD","LU0359202008.SGD","LU0181495838.USD","LU0456846285.SGD","LU0140636845.USD","LU0572944931.SGD","LU0348825331.USD","LU0819121731.USD","LU0823426480.USD","LU0307460666.USD","02269","LU1242518931.SGD","LU0039217434.USD"],"gpt_icon":0},{"id":"2584787697","title":"《股市简讯》康龙化成A股挫5%，两股东拟合计减持不超过1.5%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2584787697","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584787697?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 09:43","pubTimestamp":1763343797,"startTime":"0","endTime":"0","summary":"《股市简讯》康龙化成A股挫5%，两股东拟合计减持不超过1.5%股份* 为制药公司代工研发药物的中国康龙化成H股3759.HK周一早盘一度跌4.31%，其A股300759.SZ至多挫5%。* 该公司公告称，信中康成和信中龙成拟合计减持不超过1.5%的公司股份。* 康龙化成H股今年迄今劲涨58.3%，同期恒生指数.HSI大幅上扬32%。* 恒生生物科技指数.HSBIO盘中跌1.3%。（完）\n     更多股市简讯请点选CN-CMN-HOT(发稿 崔珠珠；审校 张喜良)((zhuzhu.cui@thomsonreuters.com; +86-21-20830048;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nL4T3WT031:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759","BK1576","300759","BK0216","BK1141"],"gpt_icon":0},{"id":"2584697529","title":"康龙化成获Norges Bank增持70.02万股 每股作价约23.81港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584697529","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584697529?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 09:20","pubTimestamp":1763342400,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　香港联交所最新资料显示，11月12日，Norges Bank增持康龙化成（03759）70.02万股，每股作价23.8072港元，总金额约为1666.98万港元。增持后最新持股数目约为1827.04万股，最新持股比例为6.21%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-11-17/doc-infxsiai5716255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1141","300759","03759","BK0216","BK1576"],"gpt_icon":0},{"id":"2584869869","title":"《细胞分选磁珠性能检测方法》国标发布，金斯瑞深度参与制定，助推行业标准化","url":"https://stock-news.laohu8.com/highlight/detail?id=2584869869","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584869869?lang=zh_cn&edition=fundamental","pubTime":"2025-11-16 20:31","pubTimestamp":1763296260,"startTime":"0","endTime":"0","summary":"日前，金斯瑞参与制定的国标GB/T 46661-2025《细胞分选用磁珠性能检测方法》正式发布，该标准是我国首次在磁珠性能检测方面形成的系统、规范性检测方法，对提升磁珠产品质量、推动细胞治疗产业标准化发展意义重大。制定中，金斯瑞凭借深厚积累，从关键环节贡献专业意见。长期以来，细胞分选磁珠技术以进口品牌为主导，国内企业面临多重挑战，发展自主可控技术成关键，但国产化突破难度极大。金斯瑞持续布局磁珠材料创新，自主研发的磁珠获行业认可，成为众多细胞治疗企业合规选择，助力超20家客户项目获批临床实验。金斯瑞深度参与彰显责任担当，将持续推进技术创新与国产化，降低关键原材料成本。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511162033379507d564&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511162033379507d564&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000320264.USD","BK1583","HK0000320223.HKD","HK0000306685.HKD","HK0000306701.USD","BK1576","BK1141","01548"],"gpt_icon":0},{"id":"2583698096","title":"医药生物行业研究周报：开源证券研究报医药生物MNC全面布局FGF21靶点 关注国内投资机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2583698096","media":"开源证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583698096?lang=zh_cn&edition=fundamental","pubTime":"2025-11-16 00:00","pubTimestamp":1763222400,"startTime":"0","endTime":"0","summary":"海外MNC 抢滩FGF21 靶点，推荐国内投资机会MASH 是基于较大患者基数、明确临床需求与商业化验证形成的确定性赛道。根据Frost & Sullivan 预测，2030 年中国及全球的MASH 患病人数将分别达到0.56亿人和4.9 亿人。MASH 创新管线众多，FGF21 能够调控脂代谢以及阻止纤维化，全球药企竞相布局。FGF21 是“多器官代谢调节器”，直击MASH 未满足需求，国内多家公司布局，推荐关注相关投资机会。其主要不良事件多为轻至中度。目前，华东医药DR10624 已围绕SHTG、MASH 等多适应症布局临床。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251116150649a6fcb099&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251116150649a6fcb099&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1242518931.SGD","LU0516423174.USD","LU0856984785.SGD","SG9999002463.SGD","BK1576","LU0516422440.USD","LU0572944931.SGD","LU0320764599.SGD","LU0307460666.USD","LU0823426308.USD","LU0417516738.SGD","LU0359201612.USD","LU0823426480.USD","LU0140636845.USD","LU0181495838.USD","LU0051755006.USD","LU0348735423.USD","SG9999002562.SGD","LU0052750758.USD","LU2039709279.SGD","LU0819121731.USD","LU0039217434.USD","IE00B0JY6N72.USD","LU0359202008.SGD","LU1720050803.USD","LU1242518857.USD","02615","LU0516422952.EUR","LU0327786744.USD","LU1688375341.USD","LU1794554557.SGD","LU1880383366.USD","BK1141","LU0708995583.HKD","01177","LU0043850808.USD","02269","LU0456846285.SGD","LU0348825331.USD","LU0516423091.SGD","LU0588546209.SGD","BK1521","LU0417516902.SGD","01801","BK1589","LU0326950275.SGD","BK1610","LU0979878070.USD","LU0516422366.SGD","LU3063872942.SGD","LU0456827905.SGD"],"gpt_icon":0},{"id":"2583509715","title":"药明生物(02269.HK)根据购股权计划获行使增发300万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2583509715","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583509715?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 21:27","pubTimestamp":1763126825,"startTime":"0","endTime":"0","summary":"格隆汇11月14日丨药明生物(02269.HK)公告，2025年11月14日，根据购股权获行使增发300万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251114/31797537.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU0516422440.USD","LU1688375341.USD","LU0039217434.USD","LU0516422952.EUR","LU2039709279.SGD","LU0823426480.USD","LU0456827905.SGD","LU1242518857.USD","LU0359202008.SGD","LU0516423174.USD","LU0327786744.USD","LU0516422366.SGD","LU0181495838.USD","LU0140636845.USD","LU0588546209.SGD","BK1610","LU0326950275.SGD","LU0417516902.SGD","LU1880383366.USD","LU0043850808.USD","BK1576","LU0516423091.SGD","BK1589","LU0051755006.USD","LU0359201612.USD","LU0708995583.HKD","LU0819121731.USD","LU1794554557.SGD","SG9999002562.SGD","LU0307460666.USD","LU0052750758.USD","SG9999002463.SGD","BK1141","LU1720050803.USD","LU0348825331.USD","LU3063872942.SGD","IE00B0JY6N72.USD","LU0417516738.SGD","LU0456846285.SGD","LU0320764599.SGD","LU0856984785.SGD","LU0348735423.USD","02269","LU1242518931.SGD","LU0572944931.SGD","LU0979878070.USD","LU0823426308.USD","BK1521"],"gpt_icon":0},{"id":"2583003686","title":"药明康德激进的全球化：正在感受双重挤压？","url":"https://stock-news.laohu8.com/highlight/detail?id=2583003686","media":"金融外参","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583003686?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 20:11","pubTimestamp":1763122260,"startTime":"0","endTime":"0","summary":"2025年前三季度，药明康德实现营业收入328.57亿元，同比增长18.61%，增速在全球医药外包行业中依然亮眼。规模在涨，利润却未同步起舞，这正是药明康德当前最真实的写照。更关键的是，药明康德所依赖的“中国优势”，“工程师红利与成本效率”正在受到双重挤压。“出海”的代价面对海外市场的种种不确定性，药明康德选择的应对方式，是走一条更激进的全球化路线。最后，药明康德还需要加强与全球资本市场的沟通，更有效地管理外界预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114201613a4a199e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114201613a4a199e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","LU1046422090.SGD","LU2242644610.SGD","LU2125910500.SGD","02359","LU0052750758.USD","BK1583","LU0320764599.SGD","LU0708995583.HKD","LU2045819591.USD","BK1141"],"gpt_icon":0},{"id":"2583770335","title":"Norges Bank增持康龙化成(03759)70.02万股 每股作价约23.81港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583770335","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583770335?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 18:57","pubTimestamp":1763117875,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，11月12日，Norges Bank增持康龙化成(03759)70.02万股，每股作价23.8072港元，总金额约为1666.98万港元。增持后最新持股数目约为1827.04万股，最新持股比例为6.21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369488.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","BK0216","300759","03759","BK1141"],"gpt_icon":0},{"id":"2583250513","title":"每日卖空追踪 | 昭衍新药 11月14日卖空量成交52.98万股，卖空比例为18.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583250513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583250513?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 16:30","pubTimestamp":1763109037,"startTime":"0","endTime":"0","summary":"昭衍新药北京时间11月14日，跌2.26%，卖空量成交52.98万股，较上一交易日增加100%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111416415795041f93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111416415795041f93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1141","BK1576"],"gpt_icon":0},{"id":"2583077686","title":"药明康德11月14日获主力加仓1540.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583077686","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583077686?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 16:15","pubTimestamp":1763108149,"startTime":"0","endTime":"0","summary":"11月14日，药明康德股价收平报105.20元，成交金额4.5亿元，换手率0.83%，振幅2.95%，量比1.08。药明康德今日主力资金净流入1540.2万元，连续4日净流入，上一交易日主力净流入3779.2万元。近一年数据显示，该股主力连续4日净流入后，次日上涨概率为53.85%，平均涨幅为2.56%。该股近5个交易日上涨1.55%，主力资金累计净流入6734.0万元，其中3个交易日为股价下跌时净流入；近20日主力资金累计净流入1.6亿元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114162123a4a10fb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114162123a4a10fb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0052750758.USD","LU0320764599.SGD","LU0708995583.HKD","BK1583","02359","LU2125910500.SGD","LU2045819591.USD","LU1046422090.SGD","BK1576","BK1141","LU2242644610.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":116,"code":"91000000","status":"200"}]}}